HLHanzhang Lu

Hanzhang Lu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hanzhang Lu has a total of 141 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An Exploratory Study on the Relationship Between Cerebrovascular Reactivity and Intravenous Gadolinium-Based Contrast Agent (GBCA) Distribution in the Cerebrospinal Fluid (CSF)

    by Jacob Varghese, Yuanqi Sun, Yinghao Li, Cuimei Xu, Chunming Gu, Adrian G. Paez, Hanzhang Lu, Jun Hua

    Background: Intravenous gadolinium-based contrast agent (IV-GBCA)-based MRI has been widely used to study cerebrospinal fluid (CSF) circulation and clearance in the human brain. IV-GBCA can enter the CSF via the choroid plexus (CP) and parasagittal dura (PSD), but how these dynamics are coupled with cerebrovascular fluctuations is unclear. The goal of this study is to investigate the relationship between microvascular reactivity and CSF distribution in the human brain, which were measured with cerebrovascular reactivity (CVR) and IV-GBCA distribution in the CSF, respectively. Methods: CVR and IV-GBCA distribution in the CSF around the CP and PSD were measured in the same five healthy subjects (four males, one female; age 40 ± 16 years) during CO2 breathing using inflow-based vascular-space-occupancy (iVASO) MRI and dynamic susceptibility contrast in the CSF (cDSC) MRI, respectively. Results: Whole-brain arterial cerebral blood volume (CBVa) increases during CO2 breathing showed a strong negative correlation with GBCA concentration in CSF around the CP but a moderate positive (but not significant) correlation in CSF around the PSD. Conclusions: The finding of a differential relationship between CVR and IV-GBCA distribution in the CSF in different brain regions highlights the importance of accounting for microvascular function in neurofluids studies using IV-GBCA-based MRI.

  • Retrospective cohort analysis of early post treatment follow-up MRI biomarkers of collateral status associated with long-term outcomes in large vessel occlusion acute ischemic stroke

    by Cynthia Greene, Hamza Adel Salim, Dhairya A. Lakhani, Andrew Cho, Derek Tsang, Karthik Lalwani, Meisam Hoseinyazdi, Sijin Wen, Jeremy J. Heit, Tobias D. Faizy, et al.

  • Open Access

    Non-invasive MRI mapping of tissue-CSF water exchange reveals glymphatic fluid movement in live human cortex

    by Zihan Wang, Zhiyi Hu, Dengrong Jiang, Jie Song, Yifan Gou, Wen Shi, Jiani Wu, Cuimei Xu, Oluwateniola Akinwale, Kaisha Hazel, et al.

    Efficient metabolic waste clearance, via the postulated glymphatic system, is essential for neural homeostasis. However, direct visualization of tissue-cerebrospinal fluid (CSF) exchange remains limited, leading to ongoing debate in the neuroscientific field. The present work revealed evidence of tissue-CSF water exchange in the live human cortex, by employing a novel MRI technique demonstrating the flux of water molecules across the perivascular interface. We observed robust water exchange inside the cortical ribbon, which was more prominent than white matter and deep brain tissue. We validated that the signal originates from CSF and is independent of cerebral perfusion. Water exchange between tissue and CSF declined with age. Furthermore, we demonstrated for the first time that tissue-CSF exchange was impaired in Alzheimer’s disease (AD), in particular in regions where the perivascular space is clogged by anti-amyloid immunotherapy.


  • Open Access

    Non‐contrast MRI of blood‐brain barrier, arterial vessel integrity, glymphatic function in ADRD and ARIA

    by Hanzhang Lu

    Background: Neurofluid exchange in the brain is critical for its normal function. Abnormalities in these exchanges are associated various clinical manifestations in the Alzheimer's disease and related dementia (ADRD) spectrum. This presentation will discuss recent advances in MRI imaging technologies to assess neurofluid exchanges at multiple interfaces and their applications in ADRD including amyloid related imaging abnormalities (ARIA). Method: We will discuss three aspects of neurofluid exchange, measured with non‐contrast MRI. Section 1 will describe imaging of blood‐brain barrier (BBB) permeability using non‐contrast MRI. MRI can measure BBB's permeability to water at the capillary‐tissue interface. Section 2 will discuss imaging of arterial vessel integrity using MRI, which can potentially serve as a surrogate marker for microbleed risks and ARIA. Section 3 will discuss the assessment of water exchange between interstitial fluid (ISF) and perivascular space (PVS) fluid, potentially related to glymphatic function. Result: BBB permeability to water was found to be elevated in patients with mild cognitive impairment (MCI), the degree of which was associated with CSF measures of beta‐amyloid 42 and ptau (Figure 1). BBB permeability was found to be related to cognitive function, in particular memory domain scores. Studies in animal models of AD confirmed these findings. Mouse models of 5xFAD and tauopathy revealed increased BBB permeability, which was confirmed by biotin tracer and could be reverted by senolytic treatment (Figure 2). ARIA is primarily attributed to arterial vessel wall breakdown, leading to proteins (ARIA‐E) or red blood cells (ARIA‐H) leaking out of vessels. Arterial‐spin‐labeling (ASL) MRI under long echo‐time (TE) can selectively measure water molecules leaking out of arteries and entering perivascular space (Figure 3). Thus, hyperintensities in long‐TE ASL images may be indicative of ARIA risks (Figure 3). On the other hand, diminished signals (hypointensities) in long‐TE ASL images may indicate reduced ISF and PVS exchange and abnormal glymphatic function. Normative long‐TE ASL images in younger and older healthy subjects have been established. Conclusion: Recent advances in MRI technologies allowed the assessment of neurofluid exchange at several interfaces. These techniques can provide important insights on the role of neurofluid in the pathogenesis of neurodegenerative diseases.

  • The hippocampal-cortical system cerebral blood flow in schizophrenia: Primary disease versus antipsychotic medication effects

    by Alexa Ciarolla, Anastasia M. Bobilev, Filip Dybowski, Yan Fang, Carolyn Sacco, Jayme M. Palka, Sina Aslan, Peiying Liu, Hanzhang Lu, Carol A. Tamminga, et al.


  • Prolonged venous transit and clinical outcomes in anterior circulation large-vessel occlusion stroke with complete or near-complete reperfusion

    by Hamza Adel Salim, Dhairya A. Lakhani, Aneri Balar, Janet Mei, Licia Luna, Mona Shahriari, Nathan Z. Hyson, Francis Deng, Adam A. Dmytriw, Adrien Guenego, et al.

    Background Prolonged venous transit (PVT), indicative of impaired venous outflow, is linked to poor outcomes in acute ischemic stroke due to large-vessel occlusion (AIS-LVO) treated with mechanical thrombectomy (MT). This study investigated the prognostic significance of PVT in AIS-LVO patients achieving near-complete or complete reperfusion (mTICI 2c or 3). Methods Retrospective analysis of a prospective registry included AIS-LVO patients with anterior circulation occlusions, mTICI 2c or 3 after MT, and 90-day modified Rankin Scale (mRS) scores. PVT, defined as Tmax ≥ 10 s in the posterior superior sagittal sinus or torcula on pretreatment CT perfusion, was assessed. Outcomes were favorable recovery (mRS 0–2), excellent recovery (mRS 0–1), and 90-day mortality. Results Among 81 patients, 25 (31%) were PVT + and 56 (69%) were PVT−. Baseline characteristics were similar. PVT + patients had higher discharge NIH Stroke Scale scores and worse 90-day mRS scores (median mRS, 4.00 vs. 1.00; P < 0.001). Multivariable analysis showed PVT + independently predicted lower odds of favorable (OR, 0.18; 95% CI, 0.04–0.65; P = 0.013) and excellent outcomes (OR, 0.12; 95% CI, 0.02–0.52; P = 0.008) and higher 90-day mortality (OR, 4.11; 95% CI, 1.08-17.0; P = 0.041). Conclusions PVT is a strong negative prognostic marker in AIS-LVO patients with excellent reperfusion, associated with reduced functional recovery and increased 90-day mortality. PVT assessment may identify high-risk patients despite successful MT.


  • Hippocampal subfield activity in schizophrenia: Effects of the disease course

    by Elena I. Ivleva, Jayme M. Palka, Anastasia M. Bobilev, Yan Fang, Carolyn Sacco, Alexa Ciarolla, Sina Aslan, Peiying Liu, Hanzhang Lu, Carol A. Tamminga


  • Open Access

    Cerebrovascular reactivity as a candidate biomarker in small vessel disease related VCID

    by Hanzhang Lu

    Background: The brain’s ability to perform a cognitive task is a dynamic process and requires small blood vessels to dilate or constrict in real time to adjust blood flow in a region‐specific manner. Cerebrovascular Reactivity (CVR) measures the ability of vessels to react to vasoactive challenges. In this work, we investigated the role of CVR as a possible biomarker in small vessel disease related vascular contributions to cognitive impairment and dementia (VCID), as part of the NINDS‐funded MarkVCID study.Methods: This work consisted of 4 studies. CVR was measured by MRI signal changes in response to inhalation of 5% carbon dioxide (CO2) (Figure 1). Study 1 was a single‐site study of 72 participants (aged 69±8 years, 28 normal cognition and 44 cognitive impairment), in which we examined the relationship between CVR and cognitive function, CSF‐measured AD pathological markers, and CDR‐sum‐of‐boxes. Study 2 conducted an instrumental validation to benchmark the test‐retest reproducibility of the CVR measure. Study 3 developed an automatic, cloud‐based tool for automatic and standardized processing of CVR MRI data. Study 4 was a multi‐site biological validation study in which CVR was measured across 3 sites and data from each site were separately analyzed to investigate the relationship between CVR and cognitive function.Results: Study 1 revealed that whole‐brain CVR was associated with MoCA (β=29.64, 95% CI, 9.94 to 49.34) and global composite scores (β=4.32, 95% CI, 0.05 to 8.58), and these associations were independent of CSF‐measured amyloid and tau markers. CVR was also associated with CDR‐SB score. Study 2 revealed that inter‐scanner CoV of CVR was 6.90 ± 5.08% and had an ICC of 0.8498. Study 3 showed that CVR processing can be standardized and the processing pipeline can be accessed by any researchers around the world through an installation‐free cloud platform referred to as MRICloud (https://braingps.mricloud.org/cvr.v5). Study 4 showed that CVR was significantly associated with MoCA in data analyzed separately in each of the three sites through a pre‐defined analysis (p=0.003, 0.002, 0.046 for the three sites, respectively; when pooling data together p=3.7*10^‐6) (Figure 2).Conclusion: CVR measured with MRI is a promising candidate biomarker in VCID.

  • Open Access

    Glymphatic influx and clearance are perturbed in Huntington’s disease

    by Hongshuai Liu, Lin Chen, Chuangchuang Zhang, Chang Liu, Yuguo Li, Liam Cheng, Yuxiao Ouyang, Catherine Rutledge, John Anderson, Zhiliang Wei, et al.

    The accumulation of mutant huntingtin protein aggregates in neurons is a pathological hallmark of Huntington’s disease (HD). The glymphatic system, a brain-wide perivascular network, facilitates the exchange of interstitial fluid and cerebrospinal fluid (CSF), supporting interstitial solute clearance of brain wastes. In this study, we employed dynamic glucose-enhanced (DGE) MRI to measure d-glucose clearance from CSF as a tool to predict glymphatic function in a mouse model of HD. We found significantly diminished CSF clearance efficiency in HD mice before phenotypic onset. The impairment of CSF clearance efficiency worsened with disease progression. These DGE MRI findings in compromised glymphatic function were further verified with fluorescence-based imaging of CSF tracer influx, suggesting an impaired glymphatic function in premanifest HD. Moreover, expression of the astroglial water channel aquaporin-4 in the perivascular compartment, a key mediator of glymphatic function, was significantly diminished in both HD mouse brain and human HD brain. Our data, acquired using a clinically translatable MRI, indicate a perturbed glymphatic network in the HD brain. Further validation of these findings in clinical studies will provide insights into the potential of glymphatic clearance as a therapeutic target as well as an early biomarker in HD.


  • Open Access

    CT Perfusion Derived rCBV < 42% Lesion Volume Is Independently Associated with Followup FLAIR Infarct Volume in Anterior Circulation Large Vessel Occlusion

    by Dhairya A. Lakhani, Aneri B. Balar, Hamza Salim, Manisha Koneru, Sijin Wen, Burak Ozkara, Hanzhang Lu, Richard Wang, Meisam Hoseinyazdi, Risheng Xu, et al.

    Pretreatment CT Perfusion (CTP) parameter rCBV < 42% lesion volume has recently been shown to predict 90-day mRS. In this study, we aim to assess the relationship between rCBV < 42% and a radiographic follow-up infarct volume delineated on FLAIR images. In this retrospective evaluation of our prospectively collected database, we included acute stroke patients triaged by multimodal CT imaging, including CT angiography and perfusion imaging, with confirmed anterior circulation large vessel occlusion between 9 January 2017 and 10 January 2023. Follow-up FLAIR imaging was used to determine the final infarct volume. Student t, Mann-Whitney-U, and Chi-Square tests were used to assess differences. Spearman’s rank correlation and linear regression analysis were used to assess associations between rCBV < 42% and follow-up infarct volume on FLAIR. In total, 158 patients (median age: 68 years, 52.5% female) met our inclusion criteria. rCBV < 42% (ρ = 0.56, p < 0.001) significantly correlated with follow-up-FLAIR infarct volume. On multivariable linear regression analysis, rCBV < 42% lesion volume (beta = 0.60, p < 0.001), ASPECTS (beta = −0.214, p < 0.01), mTICI (beta = −0.277, p < 0.001), and diabetes (beta = 0.16, p < 0.05) were independently associated with follow-up infarct volume. The rCBV < 42% lesion volume is independently associated with FLAIR follow-up infarct volume.